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1. Purpose
Clinical management of high grade gliomas (HGG) often involves antiangiogenic therapies using
monoclonal antibodies, mainly against VGEF. Responses to this treatment are highly heterogenous,
with similar cohorts of patients behaving as “responders” or “non-responders”. It would be then very
useful to discriminate by non invasive criteria the two populations as early as possible, to tailor
treatment accordingly. Here we report on a multivariate analysis approach on the discriminant power
of T2w and DWI, or their combination to predict the treatment outcome of mice bearing implanted
Gl621 tumors to anti-VGEF therapy.
2. Material and Methods
We evaluated treatment response in 13 mice bearing implanted Gl261 tumors on a 7T MR scanner
(RECIST criteria, mAb against VEGF B20-4.1, 5mg/Kg twice weekly for 8 weeks). MRI studies included
T2w and DWI performed sequentially at 3/4 day intervals until completion of treatment or obvious,
treatment independent, tumor growth. Fisher's discriminant analysis was then applied to  and Day-1
 of treatment data set in order to find the linear projection that best discriminates the pixels asDay-2
belonging to “responder” or “non-responder” animals to anti-VGEF treatment. We compared the
discriminant power of T2w alone, DWI alone or the combination of both.
3. Results
Among a total of 13 treated mice, 8 responded to treatment and 5 did not respond. Figure 1 shows the
histograms of average pixel intensities in T2w (A) and DWI (B) in responder (red) and non-responder
(blue) groups.
Figure 1
Histograms of average pixel intensities in T2w (top row) and DWI (bottom row) in responder (red)
and non responder (blue) groups. Left column: Day -1 of treatment, Middle column: Day-2 of
treatment and Right column: Day-finish of treatment. There are differences that can be used for a
classification method to predict the course of treatment.
We used the Fisher´s discriminant analysis to find out the optimal separation between these groups
using the T2w, DWI, or the combination of both imaging data sets. Using a leave one out strategy, we
obtained the following percentages of accurate predictions of a given mouse between the
“responder” and “non-responder” groups: (i) smaller than 50% using DWI only (A), (ii) 61% using T2w
images only (B) and (iii) 92% when using the combination of T2w and DWI data sets (C). Figure 2
illustrates the classification between responders (red) and “non-responders” under the three cases.
Figure 2
Result of the Fisher´s discriminant analysis and the classification of data set into “responders” (red)
and “non-responders” (blue) using DWI (top), T2w (middle) and combination of both (bottom).
4. Conclusion
We provide a protocol for the prediction of therapy response to antiangiogenic therapy in mouse
glioma models, based on non invasive parameters as T2w and DWI. Present results provide 92%
successful predictions when using combinations of T2w and DWI data sets. Prediction accuracy may
be improved by increasing the number of mice investigated or including in the discriminant function
additional perfusion parameters as CBF, CBV and MTT. The method is easily extendable for human use.
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Figure 2
Result of the Fisher´s discriminant analysis and the classification of data set into “responders” (red)
and “non-responders” (blue) using DWI (top), T2w (middle) and combination of both (bottom).
